Description
Cutaneous lymphomas are rare cancers whose study requires a widely-distributed, multidisciplinary network.
EORTC’s research in this field benefits greatly from our multi-centre, pluridisciplinary infrastructure. We focus on testing new agents in collaboration with industry and translational researchers, but also look at prospective research for prognostic index development.
CLTF Meeting 2018: videos and interviews
Related News
All newsRecruiting Clinical Trials
All clinical trials in this research fieldMain Achievements
EORTC studies in this field have defined the clinicopathological characteristics of distinct types of cutaneous lymphomas. These studies have supported the establishment of standard of care treatments, and were instrumental in updating the WHO classification for cutaneous lymphomas.
We published EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome in the 2007 European Journal of Cancer and these were updated in 2017.
We collaborated with other International Lymphoma Organisations (International Society of Cutaneous Lymphoma; ISCL) to produce Consensus Recommendations for the treatment of primary cutaneous CD30 positive T-cell lymphoproliferative disorders, published in Blood Journal in 2011. The recommendations also revised the staging and classification of both mycosis fungoides, Sezary syndrome and other non-mycosis fungoides primary cutaneous lymphomas (all published in Blood Journal in 2007).
Research Group
Group documents-
Chair
Julia Scarisbrick
University Hospitals Birmigham NHS Foundation Trust (UHB) - Queen Elizabeth Medical Centre
Birmingham, United Kingdom
-
Secretary
Antonio Cozzio
Kantonsspital St Gallen
St Gallen, Switzerland
-
Treasurer
Evangelia Papadavid
Athens University - Attikon University General Hospital
Athens, Greece
Steering Committee
-
M. Bagot - Paris, FR
Hopitaux de Paris - Hopital Saint-Louis
-
R. Knobler - Vienna, AT
Medical University Vienna - General Hospital AKH
-
S. Whittaker - London, GB
Guy's and St Thomas' NHS - St Thomas Hospital
-
P. Ortiz-Romero - Madrid, ES
Hospital Universitario 12 De Octubre
-
R. Stadler - Minden, DE
Johannes Wesling Klinikum Minden
Pathology Group
-
A. Robson - London, GB
-
G. Burg - Zurich, CH
UniversitaetsSpital Zurich
-
E. Calonje - London, GB
Guy's and St Thomas' NHS - St Thomas Hospital
-
L. Cerroni - Graz, AT
Medical University of Graz
-
W. Kempf - Zurich, CH
UniversitaetsSpital Zurich
-
R. Willemze - Leiden, NL
Leiden University Medical Centre
-
E. Berti - Milano, IT
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
Notable Publications
All publications on this research field-
2018
Blood classification and blood response criteria in mycosis fungoides and Se´zary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force
-
2017
Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials
-
2017
A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs.
-
2012
Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial 21011 (NCT00056056)
-
2012
Efficacy and safety of bexarotene combined with psoralen/ultraviolet A light (PUVA) compared to PUVA treatment alone in stage IB-IIa mycosis fungoides (MF): Final results from EORTC cutaneous lymphoma task force (CLTF) phase III clinical trial 21011